期刊文献+

脂肪组织在CYP1B1缺失保护小鼠营养性肥胖中的作用

Role of White Adipose Tissue in Protecting CYP1B1 Knock-out Mice from Obesity
原文传递
导出
摘要 目的:从脂肪组织脂肪代谢和相关内分泌功能方面探讨CYP1B1在成年小鼠营养性肥胖中的作用。方法:CYP1B1基因敲除和野生型雄性6周龄小鼠各16只,给予低、高脂饲料共6周。处理结束后分离脂肪组织,采用实时荧光定量PCR技术测定脂肪组织中相关因子表达水平,免疫印记检测葡萄糖转运蛋白4(GLUT4)表达。结果:与野生高脂组比较,基因敲除高脂组小鼠体重增量低;荧光定量PCR结果显示,敲除高脂组小鼠白介素-6(IL-6)、血管生成素2、脂肪酸结合蛋白2(AP2)等基因表达分别是野生高脂组的0.42,0.36,0.29倍,血管生成素1基因表达是野生高脂组的1.76倍。结论:CYP1B1基因缺失,可能通过对脂肪组织脂肪代谢、炎症状态、血管新生等综合影响,改善营养性肥胖及胰岛素抵抗。 Objective: To investigate the role of white adipose tissue(WAT) in protecting CYP1B1 knock-out mice from obesity.Methods: Sixteen male CYP1B1 knock-out adult mice and sixteen wild type mice(C57) were both randomly divided into low-fat-diet(LFD) and high-fat-diet(HFD) groups.The mice were scarified at the age of 12 weeks by decapitation;epididymal fat pad was collected for gene and protein expression.Results: High fat diet substaintially increased body weight gains and epididymal fat pad weight in WT mice other than KO group.IL-6,Angio2,GLUT4 expression in fat pad were upregulated by HFD and suppressed by CYP1B1 deletion,however,CYP1B1 raise Angio1 level in both LFD and HFD group.Conclusion: CYP1B1 deficiency regulates the expressions of critical factors in adipocyte metabolism,inflammation,angiogenesis and insulin signaling pathway,which may constitute a principle pathway that ameliorated obesity and the consequential insulin resistance.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第4期503-506,共4页 Medical Journal of Wuhan University
基金 国家自然科学基金资助项目(编号:30972463)
关键词 脂肪功能 CYP1B1 高脂膳食 肥胖 White Adipose Tissue Function CYP1B1 High Fat Diet Obesity
  • 相关文献

参考文献2

二级参考文献22

  • 1张同,周金培,黄文龙.抗癌药细胞色素P4501B1抑制剂的研究进展[J].药学进展,2005,29(5):197-202. 被引量:3
  • 2Poulos SP,Hausman DB,Hausman GJ.The development and endocrine functions of adipose tissue.Mol Cell Endocrinol 2010; 323:20-34.
  • 3Burgi W,Schmid K.Preparation and properties of Znalpha 2-glycoprotein of normal human plasma.J Biol Chem 1961; 236:1066-74.
  • 4Stejskal D,Karpisek M,Reutova H,et al.Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA.Clin Biochem 2008; 41:313-6.
  • 5Hirai K,Hussey HJ,Barber MD,et al.Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.Cancer Res 1998; 58:2359-65.
  • 6Dubois V,Delort L,Mishellany F,et al.Zinc-alpha2-glycoprotein:a new biomarker of breast cancer? Anticancer Res 2010; 30:2919-25.
  • 7Ceperuelo-Mallafre V,Naf S,Escote X,et al.Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity:its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat.J Clin Endocrinol Metab 2009; 94:5062-9.
  • 8Bing C,Bao Y,Jenkins J,et al.Zinc-alpha2-glycoprotein,a lipid mobilizing factor,is expressed in adipocytes and is up-regulated in mice with cancer cachexia.Proc Natl Acad Sci U S A 2004; 101:2500-5.
  • 9Bao Y,Bing C,Hunter L,et al.Zinc-alpha2-glycoprotein,a lipid mobilizing factor,is expressed and secreted by human (SGBS) adipocytes.FEBS Lett 2005; 579:41-7.
  • 10Nguyen PL,Ma],Chavarro JE,et al.Fatty acid synthase polymorphisms,tumor expression,body mass index,prostate cancer risk,and survival.J Clin Oncol 2010; 28:3958-64.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部